Small Molecular Compound for Oral Drug Delivery 

Objective & Methodologies

Cancer treatments currently on the market are known for their high toxicity and side effects, including hair loss and fatigue. Through extensive research, we have developed a small-molecule compound with high bioavailability, allowing it to efficiently penetrate cells and target tumor cells. Screening across various cell lines has demonstrated a dose-dependent response, leading to increased cancer cell suppression through targeted suppression of the Rac1 pathway.

​

Our coated, extended-release formulation minimizes the drug’s toxic effects while reinforcing our strategy to slow tumor progression. From extensive in vitro and in vivo studies, we are able to focus the indication on bladder cancer. This approach aims to transform cancer from a life-threatening disease into a manageable chronic condition.